| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.05 |
| mRNA |
SB590885 |
GDSC1000 |
pan-cancer |
AAC |
0.064 |
0.05 |
| mRNA |
AS601245 |
GDSC1000 |
pan-cancer |
AAC |
-0.068 |
0.05 |
| mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.05 |
| mRNA |
WZ4002 |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.05 |
| mRNA |
A-770041 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.05 |
| mRNA |
BI-2536 |
FIMM |
pan-cancer |
AAC |
-0.27 |
0.05 |
| mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.05 |
| mRNA |
BRD-K35604418 |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.06 |
| mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.06 |